Showing 10,441 - 10,460 results of 10,547 for search 'Looker~', query time: 2.52s Refine Results
  1. 10441

    Research on construction of public health system in China – a CiteSpace-based visualization analysis of studies published since the COVID-19 epidemic by Yuntong ZHAO, Ziyi PENG, Shuai DU, Wuqi QIU, Pei DONG, Ayan MAO

    Published 2024-11-01
    “…The research hotspots mainly focused on the medical prevention and control cooperation mechanism between disease prevention and control institutions and medical institutions, the emergency management system (monitoring and early warning, emergency response, and infectious disease treatment), talent team building (talent training, staffing, talent utilization, and evaluation), financial investment mechanism, and information technology support. …”
    Get full text
    Article
  2. 10442

    The Mechanisms of Guaranteeing the Right to Clean Air in Iran and International Documents by Fatemeh Hamidi, Maryam Afshari, Ali Mashhadi

    Published 2024-10-01
    “…Countries have come to the conclusion that the fight against this problem will only be possible through international cooperation. Therefore, taking measures to reform the existing structures based on scientific principles and applying the laws and experiences of other countries in the world to deal with air pollution are among the main priorities. …”
    Get full text
    Article
  3. 10443

    The Policy and Governance Observatory as a Facilitator of Smart and Evidence-based Governance by Atiye Yousefi, Mahdi Abdolhamid

    Published 2024-12-01
    “…In this regard, 32 observatories have been selected from more than 100 observatories.Discussion and Results The results of the conducted investigations indicate that the policy and governance observatories monitor and analyze data and information by taking advantage of extensive participation and cooperation with knowledge and information institutions. …”
    Get full text
    Article
  4. 10444
  5. 10445

    Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions by Yang Liu, Chengquan Zhao, Tiannan Wang, Yuhong Ye, Terrel Jones, Xianxu Zeng

    Published 2024-04-01
    “…The clinical significance and pathogenesis of these multiple HR-HPV infections remain uncertain, although recent two large studies demonstrate that multiple HR-HPV infections are not associated with cumulatively higher risk of high-grade cervical squamous lesion development, suggesting competitive and/or cooperative interactions among HPV genotypes. Extensive HPV genotyping aids in risk assessment and optimising clinical approaches for women with mild abnormalities in Pap cytology. …”
    Get full text
    Article
  6. 10446
  7. 10447
  8. 10448
  9. 10449

    Experimental Investigation on Shear Strength between Ultra-High-Performance Concrete and Normal Concrete Substrates by Xinghong Jiang, Hengxiang Song, Ke Li, Jing Qiang, Jing Tian

    Published 2023-01-01
    “…The shear strength of the prefabricated UHPC-post-pouring NC interface is generally low, and the maximum shear strength of 13.9 MPa obtained by the test is still lower than the recommended value of 14–21 MPa of ACI 546.3R-14. …”
    Get full text
    Article
  10. 10450

    An online emergency medical management information system using mobile computing by Sarandis Mitropoulos, Christos Mitsis, Petros Valacheas, Christos Douligeris

    Published 2025-01-01
    “…Regarding interoperability, the mobile app cooperates with the Operational Center of EKAB, while further collaboration could be achieved with other operational ambulance handling center, mainly, of the private sector. …”
    Get full text
    Article
  11. 10451

    Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis by Yirui Zhai, Liming Wang, Hong Zhao, Fan Wu, Lingxia Xin, Feng Ye, Wei Sun, Yan Song, Lijuan Niu, Huiying Zeng, Jingbo Wang, Yuan Tang, Yongwen Song, Yueping Liu, Hui Fang, Ningning Lu, Hao Jing, Shunan Qi, Wenwen Zhang, Shulian Wang, Ye-Xiong Li, Jianxiong Wu, Bo Chen

    Published 2025-03-01
    “…Methods: Registered at ClinicalTrials.gov (NCT03535259), this phase II single-arm prospective trial targeted patients with HCC with portal or hepatic vein tumor thrombosis, liver minus gross tumor volume >700 ml, and Eastern Cooperative Oncology Group Performance Status scores of 0 or 1. …”
    Get full text
    Article
  12. 10452

    Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study by Christiaan F.J. Antonides, Felix Schoenrath, Theo M.M.H. deBy, Rahatullah Muslem, Kevin Veen, Yunus C. Yalcin, Ivan Netuka, Jan Gummert, Evgenij V. Potapov, Bart Meyns, Mustafa Özbaran, David Schibilsky, Kadir Caliskan, the EUROMACS investigators

    Published 2020-06-01
    “…The median follow‐up after explantation was 26 months (range 0.3–73 months), and 82% of the patients were in New York Heart Association Class I or II. Beta‐blockers were prescribed to 85%, angiotensin‐converting enzyme inhibitors to 71%, and loop diuretics to 50% of the patients, respectively. …”
    Get full text
    Article
  13. 10453

    The additional impact of metabolic syndrome on left ventricular deformation and myocardial energetic efficiency impairment in ischemia with nonobstructive coronary arteries patient... by Chen-Yan Min, Yue Gao, Yuan Li, Yi-Ning Jiang, Ying-Kun Guo, Hua-Yan Xu, Rong Xu, Xi Liu, Li-Ting Shen, Zhi-Gang Yang

    Published 2025-01-01
    “…Using calcium channel blockers medication (β = 0.320, p = 0.001) and hypertension (β = −0.298, p = 0.002) were also independently associated with impaired MEEI. …”
    Get full text
    Article
  14. 10454

    Principles, barriers and enablers to agroecological animal production systems: a qualitative approach based on five case studies by B. Dumont, C. Barlagne, P. Cassart, J.E. Duval, A. Fanchone, J-L. Gourdine, O. Huguenin-Elie, Y. Kazakova, J. Klötzli, A. Lüscher, E. Oteros-Rozas, D. Pomies, M.G. Rivera Ferre, W.A.H. Rossing, V. Stefanova, A. Swartebroeckx, C. Zagaria

    Published 2025-02-01
    “…All case studies were very advanced in the social dimensions of agroecology, and cooperation networks were always reported among the enablers for scaling out. …”
    Get full text
    Article
  15. 10455

    Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer by Lei Wang, Yafei You, Wenzhuo He, Yu Hou, Lan Li, Li Wang, Chang Jiang, Jiahong Yi, Yaoxiong Xia, Liangping Xia

    Published 2025-01-01
    “…Patients with Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 2 had worse median PFS comparing with those with ECOG PS score of 0–1 (3.8 vs. 12.6 months, P = 0.004). …”
    Get full text
    Article
  16. 10456

    Using Human-Centered Design to Bridge Zero-Dose Vaccine Gap: A Case Study of Ilala District in Tanzania by Simon Martin Nzilibili, Hellen Maziku, Awet Araya, Ruthbetha Kateule, Millenium Anthony Malamla, Suna Salum, Furaha Kyesi, Lotalis Gadau, Tumaini Menson Haonga, Florian Tinuga, Rashid Mfaume, Zaitun Hamza, Georgina Joachim, Alice Geofrey Mwiru, Alex Benson, Oscar Kapela, Ona Machangu, Norman Jonas, Ntuli Kapologwe

    Published 2025-01-01
    “…The findings reveal that the HCD framework was impactful in increasing collaborations/cooperation with local government leaders and community ownership of the under-five vaccination initiative. …”
    Get full text
    Article
  17. 10457

    Testing the reliability of global surface temperature reconstructions of the Last Glacial Cycle with pseudo-proxy experiments by J.-P. Baudouin, N. Weitzel, M. May, L. Jonkers, A. M. Dolman, K. Rehfeld, K. Rehfeld

    Published 2025-02-01
    “…However, beyond 40 <span class="inline-formula">kyr</span> BP, age uncertainty limits the reconstruction reliability to timescales longer than 15 <span class="inline-formula">kyr</span>. …”
    Get full text
    Article
  18. 10458

    TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors by Jennifer Wagner, David Vredevoogd, Xin Yu, Dong Lu, Daniel S. Peeper, Heike M. Hermanns, Jin Wang, Harald Wajant, Daniela Siegmund

    Published 2025-01-01
    “…Complex Ia and Ib may furthermore interact and cooperate to ubiquitinate RIPK1 resulting in a modified complex Ia/b preventing complex Ia and Ib to convert to the established TNFR1-induced cytotoxic complexes IIa and IIb.…”
    Get full text
    Article
  19. 10459

    First assessment of biofouling assemblages in the northern Red Sea, an important region for marine non-indigenous species transfer by Juan Sempere-Valverde, Juan Sempere-Valverde, Eva Aylagas, Vitaly Syomin, Vitaly Syomin, Marcos A. L. Teixeira, Glafira D. Kolbasova, Glafira D. Kolbasova, Sofía Ruiz-Velasco, Sahar Chebaane, Arthur Anker, João Curdia, Ronald Cadiz, Dylan M. Cottrell, Andrea Desiderato, Luiz F. Andrade, Chakkiath Paul Antony, Carolina Bocanegra-Castano, Matilde Marzucchi, Angelo Poliseno, Doaa Baker, Basmah Alabdulaziz, Flor Torres, Ameer A. Eweida, Ameer A. Eweida, Susana Carvalho, Susana Carvalho

    Published 2025-02-01
    “…The environmental characteristics of each site were obtained by deploying temperature data loggers and through an environmental risk assessment.ResultsCommunity patterns observed from the PhQd and bulk DNA datasets revealed a clear separation of two sites within Sharma lagoon from the remaining sites. …”
    Get full text
    Article
  20. 10460

    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients... by Heather L. McArthur, Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu, Jane Lowe Meisel, Naoki Niikura, Yeon Hee Park, Gustavo Werutsky, Giampaolo Bianchini, Jay C. Andersen, Robert Kozarski, Nana Rokutanda, Barbara Pistilli, Sibylle Loibl

    Published 2025-02-01
    “…Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate consisting of a humanized IgG1 monoclonal antibody attached via a plasma-stable cleavable linker to a topoisomerase-I inhibitor payload, has shown efficacy alone or in combination with durvalumab, a selective, high-affinity anti-programmed cell death ligand 1 antibody, in early-phase clinical studies. …”
    Get full text
    Article